TABLE 5 Expected recommendations assuming decision-making according to TAILORx results.
From: PONDx: real-life utilization and decision impact of the 21-gene assay on clinical practice in Italy
Population | Treatment recommendations, n (%) | Change in CT + HT recommendations (%) | ||||
|---|---|---|---|---|---|---|
PRE-RS | POST-RS | |||||
CT + HT | HT | CT + HT | HT | |||
Overall population | N = 1683 | 824 (49%) | 859 (51%) | 420 (25%) | 1263 (75%) | −49% |
N0 | N = 1160 | 512 (44%) | 648 (56%) | 270 (23%) | 890 (77%) | −47% |
